Coverage
-
January 09, 2013
Ranbaxy Laboratories Ltd. has admitted to infringing three Purdue Pharma LP patents and agreed to waive possible antitrust claims under a deal to resolve litigation over the painkiller Oxycontin, which won approval from a New York federal judge Tuesday.
1 other articles on this case.
View all »